Merck KGaA reduced its outlook for sales and profit growth this year, citing the impact of a weak US dollar and uncertainty ...

German pharmaceutical and specialty materials group Merck KGaA on Thursday guided more cautiously for 2025 earnings, citing ...

Toward the end of his first Administration, Trump signed a similar Executive Order aimed at lowering the prices of some drugs ...

Uncertainty around pharma tariffs on and pricing policies under the Trump has much of the sector guessing what will happen ...

German healthcare and materials group Merck KGaA has dropped a surcharge on life sciences sector orders within China ...